Biopharma News : Biopharma and Pharma news from all around the world :
- Florida-Based Disaster Management Group Announces 15-Minute COVID-19 Screening Tool
- Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death, Compared to Placebo, When Given in Combination with Available Heart Failure Therapies
- FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial
- Global Nutraceuticals Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Archer Daniels Midland Co. | Technavio
- Orgs Team up for #COVID-19 Response: Resource Exchange Platforms Created for Medical/Research/Lab Supplies, Testing Inventory, Equipment and Treatment Capabilities
- LifeSciences BC Call to Action – COVID-19; All BC Medical Suppliers, Manufactures and Laboratories
- Medicine Man Technologies Launches Online Marketplace for Strategic Partners’ Dispensary Operations
- AVEO Oncology and Biodesix to Discontinue CyFi-2 Study of Ficlatuzumab in Relapsed and Refractory AML in Response to Public Health Crisis
- Organovo Holdings, Inc. Announces Adjournment of Special Meeting of Stockholders
- Castle Biosciences Posts Results of Collaborative Ocular Oncology Group Survey on the Management of Ocular Oncology Patients During the COVID-19 Pandemic
- Sun Pharmaceutical Industries, Inc. Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the U.S. For Potential COVID-19 Treatment
- Anthem Simplifies Care Provider Protocols to Help Deliver Safe, Effective and Timely COVID-19 Care
- Third Opioid Treatment Medication Unit in California Opens by Aegis Treatment Centers
- Global Allergy Immunotherapies Market 2020-2024 | Evolving Opportunities with Aimmune Therapeutics Inc. and ALK-Abelló AS | Technavio
- Global Generic Drugs Market Analysis to 2026 – Vendors Covered Include Cipla, Novartis, Valeant & Baxter International Among Others – ResearchAndMarkets.com
- Local Houston MedTech Company Begins Making Hand Sanitizer
- Global Sickle Cell Anemia Therapeutics Industry Analysis 2019 – Market Developments and Financials of Key Players – ResearchAndMarkets.com
- Grown Rogue Announces Issuance of Shares
- PCT LTD Obtains EPA Approval for Emerging Pathogens Labeling for Use Against SARS-CoV-2, the Novel Coronavirus That Causes the Disease COVID-19
- Global Stem Cell and Gene Therapy Biological Testing Market (2019 to 2025) – Potential Growth Opportunities and Areas of Focus – ResearchAndMarkets.com
- Salesforce Effectiveness is Reshaping the Pharma Industry | Quantzig’s Salesforce Analytics Experts Explain How
- Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA® (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with Active Disease
- Rising Pharmaceuticals and Laurus Labs Partner to Support the University of Minnesota to Explore the Prophylaxis Effect of Hydroxychloroquine in Essential Health Care Workers
- Outlook on the Cell Line Development Market to 2027 – Global Analysis and Forecasts – ResearchAndMarkets.com
- Pfizer Completes $1.25 Billion Sustainability Bond for Social and Environmental Impact
- Center for Organ Recovery & Education Receives Katie Coolican-Nicholas Miller Donor Care Award for Excellence in Donor Family Support
- P&G Joins Forces with the Red Cross and Red Crescent Network to Provide Emergency Relief and Serve European Communities During COVID-19 Pandemic
- MJH Life Sciences™ Transforms Clinician Education to Address the COVID-19 Global Pandemic
- Quanterix Statement on COVID-19 Preparedness, Resiliency Efforts and Business Continuity
- Walgreens Drive-Thru Isn’t Just for Prescription Pick-up Anymore, as Company Expands Product Pick-up Offering at Its Drive-Thrus Nationwide
Biotech – Biopharma News!
- Eckert & Ziegler: Executive Board Proposes Dividend and Share Split
- Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
- AEVIS VICTORIA SA: Publication of Annual Report 2019
- Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025
- Eckert & Ziegler receives CE approval for innovative irradiation applicators using 3D printing
- Correction of a release from 26/03/2020, 07:00 CET/CEST – Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results
- MEDICLIN is satisfied with the 2019 financial year – the outlook for 2020 is fraught with uncertainty
- Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals’ LNA-modified ASOs to effectively block important immunosuppressive pathway
- PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR 2019
- Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option
- Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option
- EVOTEC SE FISCAL YEAR 2019 RESULTS: EXCELLENT 2019 PERFORMANCE; VERY GOOD OUTLOOK FOR CONTINUED GROWTH 2020
- Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results
- HAEMATO AG: Preliminary IFRS results 2019
- Dermapharm continues its profitable growth in 2019
- 4SC AG provides results for financial year 2019 and outlook
- Drägerwerk AG & Co. KGaA: Dräger terminates series D participation certificates
- RHÖN-KLINIKUM AG Focuses on Best Possible Care of Patients in Current Corona Crisis Following Increase in Revenues in 2019
- Biofrontera AG: Biofrontera AG withdraws subscription offers for mandatory convertible bonds
- MagForce AG and Hufeland Klinikum GmbH Announce Cooperation Agreement and Opening of a New NanoTherm Treatment Center in Thuringia, Germany
- COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines
- CO.DON AG: Repeat GMP certification successfully received for the Teltow site
- Secarna Pharmaceuticals announces the acquisition of LNAplusTM based antisense drug candidates by Lipigon Pharmaceuticals
- Vita 34 successfully concludes also fourth quarter 2019 with organic growth
- Eckert & Ziegler Classified in California as Essential Business
- Biofrontera AG: Biofrontera implements comprehensive measures to reduce costs during COVID-19 pandemic
- Medios AG acquires Kölsche Blister GmbH and raises debt capital to finance growth and possible future acquisitions
- Medios AG acquires Kölsche Blister GmbH and raises debt capital
- ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company
- EVOTEC SE TO REPORT FISCAL YEAR 2019 RESULTS ON 26 MARCH 2020
- Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
- CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION WITH TOTALSTONE LLC
- Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic
- HEXO Corp to Release Second Quarter 2020 Financial Results and Host Investor Conference Call
- Smile Direct Club Donates Medical-Grade Face Shields to The Hospital for Sick Children in Toronto
- Syneos Health Launches Ventilator Initiative to Raise Awareness of Bridging Option to Address Ventilator Shortage for COVID-19 Patients
- BioStem Life Sciences Announces ISBT 128 Registration via ICCBBA
- Cubii’s Free Virtual Exercise Classes Help Participants Stay Active During Shelter-in-Place
- PDS Biotechnology Reports Full Year 2019 Financial Results and Provides Business Update
- electroCore Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park Capital
- Publication of the annual report and invitation to the ordinary and extraordinary shareholders’ meetings
- EssilorLuxottica: Disclosure of transactions in own shares
- EssilorLuxottica: Suspension of Share Buyback Program
- Tauriga Sciences, Inc. Products Fully Compliant With the Updated Regulations Established by the Florida Department of Agriculture and Consumer Services
- Radient Announces the Initiation of an At-the-Market Equity Program and Provides an Update on Initiatives to Meet Customer Demand During COVID-19 Pandemic, Financing Activities and Liquidity
- IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA
- Novartis Cosentyx® gains positive CHMP opinion for new indication in the axial spondyloarthritis spectrum
- AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal muscular atrophy (SMA)
- Vycor Medical Reports Financial Results for the year ended December 31st, 2019
- Passage Bio to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
- Allied Corp. Announces Appointment of Chief Financial Officer
- AgraFlora Organics’ GTA Facility Receives Amendments Necessary to Launch CBD Business
- Bavarian Nordic Announces Result of the Rights Issue
- Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma
- Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
- Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
- Afya Limited Announces Fourth Quarter and Full Year 2019 Financial Results
- Smile Direct Club to Produce Face Shields for Medical Personnel Amidst COVID-19 Pandemic
- SEGRA ANNOUNCES APPOINTMENT OF JAMIE BLUNDELL AS CEO
- Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 137,236,000
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News